Jian Xu

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Long Noncoding Rna

Cell Proliferation

Top Venues

Cancer medicine

OncoTargets and therapy

International journal of general medicine

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jiahui Gu, Shengrui Yang, Xueying Wang, Yining Wu, Jia Wei, Jian Xu
Hypoxic lung adenocarcinoma-derived exosomal miR-1290 induces M2 macrophage polarization by targeting SOCS3. Cancer medicine (2023)
Jiahui Gu, Shengrui Yang, Xueying Wang, Yining Wu, Jia Wei, Jian Xu
Hypoxic lung adenocarcinoma-derived exosomal miR-1290 induces M2 macrophage polarization by targeting SOCS3. Cancer medicine (2023)
Jiahui Gu, Shengrui Yang, Xueying Wang, Yining Wu, Jia Wei, Jian Xu
Hypoxic lung adenocarcinoma-derived exosomal miR-1290 induces M2 macrophage polarization by targeting SOCS3. Cancer medicine (2023)
Juan Xu, Ziwei Sun, Huanyu Ju, Erfu Xie, Yuan Mu, Jian Xu, Shiyang Pan
Construction of Novel Prognostic Nomogram for Mucinous and Signet Ring Cell Colorectal Cancer Patients with a Survival Longer Than 5 Years. International journal of general medicine 15 (2022)
Shun Zhou, Jian Xu, Dong Wang, Yong Wang, Lijuan Meng
Development an Immune-Related MicroRNA Risk Index in Hepatocellular Carcinoma. Journal of oncology 2022 (2022)
Hong Wang, Lin Wang, Hanyu Liang, Jia Wei, Yining Wu, Xueying Wang, Jian Xu
Falsely decreased FVIII activity following pneumatic tube transport. International journal of laboratory hematology 43 (2) (2020)
Yining Wu, Jia Wei, Wei Zhang, Mengxiao Xie, Xueying Wang, Jian Xu
Serum Exosomal miR-1290 is a Potential Biomarker for Lung Adenocarcinoma. OncoTargets and therapy 13 (2020)